Accepted for Publication: November 2, 2021.
Published: December 29, 2021. doi:10.1001/jamanetworkopen.2021.41328
Correction: This article was corrected on February 18, 2022, to fix omitted information on the data and safety monitoring board.
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Diaz R et al. JAMA Network Open.
Corresponding Author: Deepak L. Bhatt, MD, MPH, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115 (dlbhattmd@post.harvard.edu).
Author Contributions: Dr Diaz and Ms Castellana had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Diaz, Orlandini, Castellana, Caccavo, P. Corral, G. Corral, Chacón, Lamelas, Botto, Díaz, Domínguez, Pascual, Galatte, Jolly, Miró, Eikelboom, Maggioni, Bhatt, Yusuf.
Acquisition, analysis, or interpretation of data: Diaz, Orlandini, Castellana, Caccavo, P. Corral, G. Corral, Chacón, Botto, Domínguez, Rovito, Scarafia, Sued, Gutierrez, Jolly, Miró, Eikelboom, Loeb, Maggioni, Bhatt, Yusuf.
Drafting of the manuscript: Diaz, Orlandini, Castellana, Caccavo, P. Corral, G. Corral, Lamelas, Díaz, Domínguez, Pascual, Rovito, Galatte, Scarafia.
Critical revision of the manuscript for important intellectual content: Diaz, Orlandini, Castellana, Caccavo, P. Corral, G. Corral, Chacón, Lamelas, Botto, Sued, Gutierrez, Jolly, Miró, Eikelboom, Loeb, Maggioni, Bhatt, Yusuf.
Statistical analysis: Orlandini, Castellana, Domínguez, Scarafia, Eikelboom, Yusuf.
Obtained funding: Orlandini, Yusuf.
Administrative, technical, or material support: Orlandini, Castellana, Caccavo, P. Corral, Chacón, Botto, Díaz, Pascual, Rovito, Galatte, Sued, Gutierrez, Jolly, Loeb, Bhatt.
Supervision: Diaz, Orlandini, Castellana, Caccavo, P. Corral, Lamelas, Botto, Díaz, Galatte, Gutierrez, Jolly, Miró, Bhatt.
Conflict of Interest Disclosures: Dr Orlandini reported receiving grants from Population Health Research Institution during the conduct of the study. Dr Lamelas reported receiving personal fees from Boston Scientific, Medtronic, Edwards, and Meril outside the submitted work. Dr Miró reported receiving grants from Angelini, Contrafect, Gilead Sciences, MSD, Novartis, Pfizer, and ViiV Healthcare and personal fees from Gilead Sciences, Jansen, Lysovant, Medtronic, MSD, Novartis, and Pfizer outside the submitted work. Dr Eikelboom reported receiving grants and personal fees from Astra-Zeneca, Bayer, Boehringer-Ingelheim, Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Janssen, and Sanofi-Aventis and personal fees from Daiichi-Sankyo, Eli-Lilly, and Servier during the conduct of the study. Dr Loeb reported receiving personal fees from Seqirus, Sanofi, Medicago, Pfizer, and Merck outside the submitted work. Dr Maggioni reported receiving personal fees from Bayer, Novartis, Fresenius, and AstraZeneca outside the submitted work. Dr Bhatt reported receiving grants from Amarin, AstraZeneca, Forest Laboratories, Bristol Myers Squibb, Eisai, Ethicon, Medtronic, Sanofi Aventis, The Medicines Company, Roche, Pfizer, Ischemix, Cardax, Amgen, Lilly, Chiesi, Ironwood, PhaseBio, Idorsia, Synaptic, Abbott, Regeneron, Novo Nordisk, Fractyl, Cereno Scientific, Afimmune, Ferring Pharmaceuticals, Contego Medical, CellProthera, Lexicon, MyoKardia, Owkin, HLS Therapeutics, Janssen, 89Bio, Garmin, PLxPharma, and Novartis; personal fees from Duke Clinical Research Institute, Mayo Clinic, Population Health Research Institute, American College of Cardiology, Belvoir Publications, Slack Publications, WebMD, Elsevier, Society of Cardiovascular Patient Care, HMP Global, Harvard Clinical Research Institute (now Baim Institute for Clinical Research), Journal of the American College of Cardiology, American Heart Association, Cleveland Clinic, Mount Sinai School of Medicine, TobeSoft, Boehringer Ingelheim, Bayer, Medtelligence/ReachMD, CSL Behring, MJH Life Sciences, Level Ex, K2P, and Canadian Medical and Surgical Knowledge Translation Research Group; serving as a site coinvestigator for Abbott, Biotronik, Boston Scientific, CSI, St. Jude Medical (now Abbott), Philips, and Svelte; performing unfunded research for FlowCo, Merck, and Takeda; serving on an advisory board for Medscape Cardiology and Regado Biosciences; serving as a deputy editor for Clinical Cardiology and on the publications committee for VA CART Research and Publications Committee; and serving on the board of directors for Boston VA Research Institute No other disclosures were reported.
Funding/Support: The Population Health Research Institute contributed fees to the investigators. Fundacion ECLA funded all other aspects of the trial.
Role of the Funder/Sponsor: Fundacion ECLA was responsible for the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
The ECLA PHRI COLCOVID Trial Investigators: The ECLA PHRI COLCOVID Trial Investigators are listed in Supplement 3.
Data Sharing Statement: See Supplement 4.
Additional Contributions: Roles of committee and other members of the ECLA PHRI COLCOVID Trial Group include the following: Executive Committee: Rafael Diaz, MD (chair); Andrés Orlandini, MD (cochair); Omar Sued, MD; Pablo Corral, MD; Gonzalo Corral, MD; Carolina Chacón, MD; María Luz Díaz, MD; Alberto Caccavo, MD; Fernando Botto, MD; Pablo Lamelas, MD; Juan Manuel Dominguez, MD; José M Miro, PhD; and Sanjit S. Jolly, MD, MSc; Event Adjudication Committee: Pablo Corral, MD (cochair); Gonzalo Corral, MD, (cochair); María Luz Díaz, MD; Juan Manuel Dominguez, MD; and Agustina Galatte, MD; Data and Safety Monitoring Board (DSMB): Salim Yusuf, DPhil (chair); Aldo Pietro Maggioni, PhD; Mark Loeb, MD, MSc; Michael Szarek, PhD; and Deepak L. Bhatt, MD, MPH; Statistician Reporting to DSMB: Noelia Castellana, MSc; Study Statisticians and Programmers: Noelia Castellana, MSc (chair); Franco Scarafia, MSc; and Pablo Lamelas, MD; Trial Central Coordinating Office: Andrea Pascual, Ing; Carla Rovito, MRA; Mauricio Salvador, JD; Maximiliano Guerrero, CPA; Martin Arrieta, Adm; and Miguel A. Cabezón, BIOCH.
1.Richardson
S , Hirsch
JS , Narasimhan
M ,
et al; the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area.
JAMA. 2020;323(20):2052-2059. doi:
10.1001/jama.2020.6775
PubMedGoogle ScholarCrossref 4.Pan
H , Peto
R , Henao-Restrepo
AM ,
et al; WHO Solidarity Trial Consortium. Repurposed antiviral drugs for COVID-19—interim WHO solidarity trial results.
N Engl J Med. 2021;384(6):497-511. doi:
10.1056/NEJMoa2023184
PubMedGoogle Scholar 14.Harris
PA , Taylor
R , Thielke
R , Payne
J , Gonzalez
N , Conde
JG . Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support.
J Biomed Inform. 2009;42(2):377-381. doi:
10.1016/j.jbi.2008.08.010
PubMedGoogle ScholarCrossref 15.RECOVERY Collaborative Group. Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Lancet Resp Med. Published online October 18, 2021. doi:
10.1016/S2213-2600Google Scholar 16.Tardif
JC , Bouabdallaoui
N , L’Allier
PL ,
et al Efficacy of colchicine in non-hospitalized patients with COVID-19.
medRxiv. Preprint posted online January 27, 2021. doi:
10.1101/2021.01.26.21250494Google Scholar 17.Deftereos
SG , Giannopoulos
G , Vrachatis
DA ,
et al; GRECCO-19 investigators. Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the GRECCO-19 randomized clinical trial.
JAMA Netw Open. 2020;3(6):e2013136. doi:
10.1001/jamanetworkopen.2020.13136
PubMedGoogle Scholar 18.Lopes
MI , Bonjorno
LP , Giannini
MC ,
et al. Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial.
RMD Open. 2021;7(1):e001455. doi:
10.1136/rmdopen-2020-001455
PubMedGoogle Scholar